Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1131693

Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine


Tešija Kuna, Andrea; Đerek, Lovorka; Drvar, Vedrana; Kozmar, Ana; Gugo, Katarina
Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine // Biochemia Medica, 31 (2021), 2; 1-20 doi:10.11613/bm.2021.020502 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1131693 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine

Autori
Tešija Kuna, Andrea ; Đerek, Lovorka ; Drvar, Vedrana ; Kozmar, Ana ; Gugo, Katarina

Izvornik
Biochemia Medica (1330-0962) 31 (2021), 2; 1-20

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
antinuclear antibodies ; autoimmunity ; recommendations ; harmonization

Sažetak
Antinuclear antibodies (ANA) represent a family of autoantibodies targeting ubiquitous cellular constituents and are a hallmark of systemic inflammatory autoimmune rheumatic diseases named connective tissue diseases (CTD). The gold standard method for ANA determination is indirect immunofluorescence (IIF) on the human laryngeal epidermoid carcinoma cell line type 2 substrate (HEp-2), but with increasing demand for ANA testing, novel methods eased for automation emerged, which allows testing by staff less experienced in this specific field of laboratory diagnostic. In 2016 The working group (WG) for laboratory diagnostics of autoimmune diseases as part of the Committee for the Scientific Professional Development of the Croatian Society of Medical Biochemistry and Laboratory Medicine (CSMBLM) published the data of a survey regarding general practice in laboratory diagnostics of autoimmune diseases in Croatia. Results indicated high diversity in the performance of autoantibody testing as well as reporting of the results and indicated the need of creating recommendations for the assessment of ANA that would help harmonize diagnostics of systemic autoimmune rheumatic diseases in Croatia. This document encompasses twenty-seven recommendations for ANA testing created concerning indications for ANA testing, preanalytical, analytical, and postanalytical issues, including rational algorithm and quality control assurance. These recommendations are based on the relevant international recommendations and guidelines for the assessment of ANA testing and relevant literature search and should help to harmonize the approach in ANA testing and clarify differences in interpretation of the results obtained using different methods of determination

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove:
KBC "Sestre Milosrdnice",
KBC Split,
Klinička bolnica "Dubrava",
Medicinski fakultet, Split,
Klinički bolnički centar Rijeka

Profili:

Avatar Url Andrea Tešija Kuna (autor)

Avatar Url Katarina Gugo (autor)

Avatar Url Ana Kozmar (autor)

Poveznice na cjeloviti tekst rada:

doi www.biochemia-medica.com

Citiraj ovu publikaciju:

Tešija Kuna, Andrea; Đerek, Lovorka; Drvar, Vedrana; Kozmar, Ana; Gugo, Katarina
Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine // Biochemia Medica, 31 (2021), 2; 1-20 doi:10.11613/bm.2021.020502 (međunarodna recenzija, članak, znanstveni)
Tešija Kuna, A., Đerek, L., Drvar, V., Kozmar, A. & Gugo, K. (2021) Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine. Biochemia Medica, 31 (2), 1-20 doi:10.11613/bm.2021.020502.
@article{article, author = {Te\v{s}ija Kuna, Andrea and \DJerek, Lovorka and Drvar, Vedrana and Kozmar, Ana and Gugo, Katarina}, year = {2021}, pages = {1-20}, DOI = {10.11613/bm.2021.020502}, keywords = {antinuclear antibodies, autoimmunity, recommendations, harmonization}, journal = {Biochemia Medica}, doi = {10.11613/bm.2021.020502}, volume = {31}, number = {2}, issn = {1330-0962}, title = {Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine}, keyword = {antinuclear antibodies, autoimmunity, recommendations, harmonization} }
@article{article, author = {Te\v{s}ija Kuna, Andrea and \DJerek, Lovorka and Drvar, Vedrana and Kozmar, Ana and Gugo, Katarina}, year = {2021}, pages = {1-20}, DOI = {10.11613/bm.2021.020502}, keywords = {antinuclear antibodies, autoimmunity, recommendations, harmonization}, journal = {Biochemia Medica}, doi = {10.11613/bm.2021.020502}, volume = {31}, number = {2}, issn = {1330-0962}, title = {Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine}, keyword = {antinuclear antibodies, autoimmunity, recommendations, harmonization} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font